French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.
Sanofi's chief executive Olivier Brandicourt said the acquisition "enhances its presence in specialty care and leadership in rare diseases... and creates a platform for growth in other rare blood disorders."
The purchase shouldRead more
The Philippines said Friday it had suspended a landmark public vaccination programme for the potentially deadly dengue virus after its manufacturer warned it could worsen the disease in some cases.
French pharmaceutical giant Sanofi announced Wednesday that its world-first dengue vaccine could lead to more severe symptoms for people who had not previously been infected.
The Philippines has vaccinated moreRead more
The Philippines is prepared for a "worst-case scenario" following warnings that an anti-dengue vaccine administered to thousands of children may worsen the disease in some cases, a health official said Saturday.
Department of Health spokesman Eric Tayag said the country had already taken precautions against potential mishaps when it became the first country to use the landmark vaccine in 2016.Read more